THIS SHARE EXCHANGE AGREEMENT made as of the 15th day of September, 1998. B E T W E E N: GLYKO BIOMEDICAL LTD., a corporation incorporated under the laws of Canada, (hereinafter called the "Vendor") OF THE FIRST PART;Share Exchange Agreement • November 16th, 1998 • Glyko Biomedical LTD • In vitro & in vivo diagnostic substances
EXHIBIT 2.2 ACQUISITION AGREEMENT FOR A PLAN OF ARRANGEMENT BY AND AMONG BIOMARIN PHARMACEUTICAL INC., BIOMARIN ACQUISITION (NOVA SCOTIA) COMPANY,Acquisition Agreement • April 1st, 2002 • Glyko Biomedical LTD • In vitro & in vivo diagnostic substances • Delaware
LICENSE AGREEMENT This LICENSE AGREEMENT (the "Agreement") is made and entered into as of June 26, 1997, by and between Glyko Biomedical Ltd, ("Glyko"), a Canadian corporation having its offices at Cassels Brock Blackwell, 40 King Street West, 21st...License Agreement • November 14th, 1997 • Glyko Biomedical LTD • In vitro & in vivo diagnostic substances • California
